Immunocore Holdings plc American Depositary Shares (IMCR) is a publicly traded Healthcare sector company. As of May 21, 2026, IMCR trades at $29.54 with a market cap of $1.44B and a P/E ratio of -54.60. IMCR moved +2.14% today. Year to date, IMCR is -9.80%; over the trailing twelve months it is -8.80%. Its 52-week range spans $23.15 to $40.71. Analyst consensus is buy with an average price target of $62.33. Rallies surfaces IMCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IMCR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IMCR recently traded at $29.54. Market cap is $1.44B. P/E ratio is -54.60. Revenue is $412.81M.
| Metric | Value |
|---|---|
| Price | $29.54 |
| Market Cap | $1.44B |
| P/E Ratio | -54.60 |
| EPS | $-0.54 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.71 |
| 52-Week Low | $23.15 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $412.81M |
| Net Income | $-27.57M |
| Gross Margin | 98.86% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $400.02M | $-35.51M | $-0.71 |
| 2024 | $310.20M | $-51.09M | $-1.02 |
| 2023 | $249.43M | $-55.29M | $-1.13 |
10 analysts cover IMCR: 0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $62.33.